Compare Enveric Biosciences Inc (ENVB) vs Novavax Inc (NVAX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Enveric Biosciences Inc vs Novavax Inc — how do they compare? Enveric Biosciences Inc trades at $1.45 (market cap $6.20M), while Novavax Inc trades at $7.96 (market cap $1.31B). The key difference: Novavax Inc is far larger — about 211.3× Enveric Biosciences Inc's market cap, and Novavax Inc is trading nearer its 52-week high, Enveric Biosciences Inc nearer its low. Which is the better fit depends on your goals.
| ENVB | NVAX | |
|---|---|---|
Market Cap | $6.20M | $1.31B |
Sector | Health | Health |
52-Week High | $17.40 | $11.19 |
52-Week Low | $1.27 | $6.22 |
Enterprise Value | $1.30M | $889.30M |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Enveric Biosciences Inc
Enveric Biosciences is a biotechnology company focused on developing next-generation psychedelic-inspired therapies for mental health and neuropsychiatric disorders.
Read more on ENVB →About Novavax Inc
Novavax, Inc. is a clinical stage biotechnology company. The Company creates novel vaccines to address a broad range of infectious diseases worldwide using proprietary virus-like particle (VLP) technology.
Read more on NVAX →
